Maiken Keson-Brookes
Plus aucun poste en cours
Fortune : 224 974 $ au 31/03/2024
Provenance du réseau au premier degré de Maiken Keson-Brookes
Entité | Type d'entité | Industrie | |
---|---|---|---|
81
| Public Company | Pharmaceuticals: Major | 81 |
Private Company | Biotechnology | 23 | |
FORUM Pharmaceuticals, Inc.
FORUM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology FORUM Pharmaceuticals, Inc. was engaged in the development of therapeutics for disorders of the central nervous system (CNS). It focused on discovering and developing treatments for important neurodegenerative diseases that explore novel mechanisms of action to potentially alter the progression of brain disease and provided improvement in cognitive and overall function. The company was founded by Thorsten Melcher in 2001 and was headquartered in Waltham, MA.
15
| Extinct | Pharmaceuticals: Major | 15 |
Public Company | Biotechnology | 4 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Maiken Keson-Brookes via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
AMGEN INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal | |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Corporate Officer/Principal Director of Finance/CFO | |
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
IMMUNOGEN, INC. | Biotechnology | General Counsel Director of Finance/CFO General Counsel | |
MERCK & CO., INC. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
PFIZER, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Human Resources Officer | |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO Corporate Officer/Principal | |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
NEUROCRINE BIOSCIENCES, INC. | Pharmaceuticals: Major | Chairman Director/Board Member Corporate Officer/Principal | |
ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Investor Relations Contact | |
HALOZYME THERAPEUTICS, INC. | Biotechnology | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
IDENIX PHARMACEUTICALS INC | Pharmaceuticals: Major | Investor Relations Contact Corporate Officer/Principal | |
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | Pharmaceuticals: Major | Founder Director/Board Member | |
BG MEDICINE, INC. | Medical Specialties | Director/Board Member Founder Director/Board Member | |
RADIUS HEALTH, INC. | Biotechnology | Director/Board Member Director of Finance/CFO Investor Relations Contact | |
ASTRIA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member General Counsel | |
RECEPTOS INC | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer Director of Finance/CFO | |
NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Doctorate Degree Corporate Officer/Principal Doctorate Degree Undergraduate Degree Doctorate Degree | |
Stanford University | College/University | Masters Business Admin Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
University of Pennsylvania | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree | |
TAKEDA PHARMACEUTICAL COMPANY LIMITED | Pharmaceuticals: Major | Director/Board Member Comptroller/Controller/Auditor Corporate Officer/Principal Corporate Officer/Principal | |
Boston University | College/University | Undergraduate Degree Masters Business Admin Masters Business Admin | |
Leerink Partners LLC
Leerink Partners LLC Investment Banks/BrokersFinance Leerink Partners LLC is a full-service brokerage and investment banking firm headquartered in Boston, Massachusetts. The firm was founded by Jeffrey Leerink in 1995 and formerly known as SVB Securities LLC. They rebranded as Leerink Partners in 2023. The firm is a subsidiary of SVB Securities LLC. Leerink Partners provides institutional sales, equity research, institutional trading, and corporate finance and asset management services to the healthcare and technology industries. They offer superior execution capabilities in common stock, convertibles and derivatives with a singular focus on healthcare and a knowledge-led approach. | Investment Banks/Brokers | Consultant / Advisor Director/Board Member Analyst-Equity | |
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Consultant / Advisor Consultant / Advisor Consultant / Advisor | |
Flagship Pioneering
Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Chief Executive Officer Corporate Officer/Principal Private Equity Investor Private Equity Investor | |
ALNYLAM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Massachusetts Institute of Technology | College/University | Undergraduate Degree Corporate Officer/Principal Director/Board Member Undergraduate Degree Graduate Degree | |
Northwestern University
Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Director/Board Member Undergraduate Degree Undergraduate Degree | |
Louisiana State University | College/University | Corporate Officer/Principal Doctorate Degree | |
Yale University | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree Doctorate Degree | |
Montclair State University | College/University | Director/Board Member Undergraduate Degree | |
University of Michigan | College/University | Masters Business Admin Undergraduate Degree | |
University of Phoenix | College/University | Masters Business Admin Masters Business Admin | |
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The private company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel Corporate Officer/Principal Chairman Director/Board Member Director of Finance/CFO Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
MIT Sloan School of Management | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
VOYAGER THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Chief Executive Officer | |
AKCEA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal | |
SCHOLAR ROCK HOLDING CORPORATION | Biotechnology | Director/Board Member Chairman Director/Board Member Human Resources Officer | |
EVELO BIOSCIENCES, INC. | Pharmaceuticals: Major | Founder Chairman General Counsel | |
BIOVERATIV INC | Biotechnology | Chairman General Counsel Public Communications Contact | |
Biogen GmbH
Biogen GmbH Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen GmbH is a pioneer in the field of neuroscience since 1978. The private company is based in Ismaning, Germany. Biogen focuses on research in therapeutic areas with a strong emphasis on difficult-to-treat diseases. The German company was founded in 1978 by Charles Weissman, Kenneth Murray, Heinz Schaller, Phillip Sharp, Walter Gilbert. The CEO is Michel Pericles Vounatsos. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
BIOMX INC. | Biotechnology | Director/Board Member Director/Board Member | |
HotSpot Therapeutics, Inc.
HotSpot Therapeutics, Inc. BiotechnologyHealth Technology HotSpot Therapeutics, Inc. develops new allosteric therapies with the ability to treat disease. The company was founded by Jonathan Montagu and Geraldine Harriman and is headquartered in Boston, MA. | Biotechnology | Director/Board Member Director/Board Member | |
VERVE THERAPEUTICS, INC. | Biotechnology | Founder Director/Board Member |
Statistiques
Internationale
Etats-Unis | 46 |
Suisse | 2 |
Japon | 2 |
Allemagne | 2 |
Israël | 2 |
Sectorielle
Health Technology | 34 |
Consumer Services | 12 |
Finance | 6 |
Opérationnelle
Director/Board Member | 319 |
Corporate Officer/Principal | 245 |
Independent Dir/Board Member | 105 |
Undergraduate Degree | 91 |
Chairman | 80 |
Relations les plus connectées
Insiders | |
---|---|
Noubar Afeyan | 75 |
David Epstein | 28 |
Faheem Hasnain | 27 |
Stelios Papadopoulos | 26 |
William Rastetter | 24 |
Burt Adelman | 23 |
Mary L. Good | 21 |
Peter Kellogg | 21 |
Brian Posner | 19 |
Alessandra Cesano | 19 |
Deborah Dunsire | 19 |
William R. Rohn | 17 |
Nancy L. Leaming | 16 |
Pratik Multani | 16 |
Lynne Sullivan | 16 |
- Bourse
- Insiders
- Maiken Keson-Brookes
- Connexions Sociétés